Clinical Trials on Ictal-Interictal Continuum in Hong Kong
Total 1 results
-
Hospital Authority, Hong KongKirin Pharmaceutical (Asia) CO., LTDCompletedAnemia | Kidney Failure, Chronic | Peritoneal Dialysis, Continuous AmbulatoryChina
Sponsors and Collaborators
- Alessandra Palo
- Gregorio Covino
- EMET Pharmaceuticals, LLC
- Invicta Medical Inc.
- Yancheng City NO.1 People's Hospital
- Irish Endocrine Society
- CARITAS Rundum zu Hause betreut
- CeRSM
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Aga Khan Foundation, Pakistan
- Outpatient Endovascular and Interventional Society
- Saint Pierre Institute - Palavas les Flots
- Grünenthal Denmark ApS
- Phramongkutklao College of Medicine and Hospital
- Eastman Kodak Company
- Erzurum Regional Training & Research Hospital
- Doterra Healing Hands Foundation
- YASEMİN AYDIN KARTAL
- Department of Anesthesiology, North Denmark Regional Hospital
- Axon Neuroscience SE
- View Full List
Medical Conditions
- Joint Arthroplasty
- Shoulder Arthropathy
- Contingent Versus Noncontingent Incentives
- Animal-assisted Intervention
- Etomidate Overdose of Undetermined Intent
- B-cell Acute Lymphoblastic Leukemia
- Lip and Oral Cavity Cancer
- Canaloplasty
- Cough Variant Asthma
- Chemotherapy-induced Febrile Neutropenia (FN)
- Active Cocaine Users
- Desquamative Interstitial Pneumonia
- Blood Sampling
- MEK Inhibitor-Associated Serous Retinopathy
- Refractory Malignant Skin Neoplasm
- Corticobasal Degeneration
- Fibromyoma;Cervix
- Adult Myxopapillary Ependymoma
- Retroperitoneal Disease
- Documented Silent Ischemia
- View Full List
Drug Interventions
- Enteral oxygen therapy
- LY2216684
- Apatinib
- Pacritinib
- Carbetocin
- Systemic intravenous lidocaine infusion
- Test varnish
- Risperidone
- MYL-1501D product using manufacture process VI
- Amantadine Sulfate
- Naltrexone 50 Mg + Inactive Marijuana (0% THC)
- Leuprolide acetate 11.25 mg
- Betamethasone
- Anti-PD1 antibody, nimotuzumab and capecitabine
- Lenalidomide
- Ranitidine
- Pregabalin
- Niraparib
- Neridronate
- Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Belarus
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Norway
- Contract Research Organizations in Oman
- Contract Research Organizations in Panama
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Sweden
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Venezuela
- CRO list by country